17
1
7
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T36982 |
CXCR3 Antagonist 6c
|
||
CXCR3 antagonist 6c is an antagonist of chemokine (C-X-C motif) receptor 3 (CXCR3).1It inhibits calcium mobilization induced by chemokine (C-X-C motif) ligand 11 (CXCL11) in HEK293 cells expressing the human receptor (IC50= 0.06 μM). It is selective for CXCR3 over a panel of 14 human G protein-coupled receptors at 10 μM. CXCR3 antagonist 6c inhibits CXCR3-mediated migration of isolated human T cells (IC50= ~100 nM). 1.Cole, A.G., Stroke, I.L., Brescia, M.-R., et al.Identification and initial eva... | |||
T10297L |
AMG 487
|
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
AMG 487 是可口服的选择性趋化因子受体3拮抗剂,对 I-IP-10、I-ITAC 和 MIG 的 IC50 值分别为 8、15 和 36nM。 | |||
T26035 |
rac-NBI-74330
rac NBI 74330,racNBI74330 |
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
rac-NBI-74330是一种有效的、选择性的 CXCR3拮抗剂。 | |||
T35085 |
VUF-11222
VUF 11222 |
||
VUF-11222 is an agonist of high affinity non-peptide CXCR3 agonist (pKi = 7.2). | |||
T7499 |
TAK-779
Takeda 779 |
HIV Protease; CXCR; CCR | Autophagy; GPCR/G Protein; Immunology/Inflammation; Microbiology/Virology; Proteases/Proteasome |
TAK-779 (Takeda 779) 是一种非肽类CCR5和CXCR3 拮抗剂,对CCR5的Ki 值为 1.1 nM,并选择性抑制R5 HIV-1。 | |||
T3360 |
ZK 756326
ZK756326 2HCl |
CCR | Immunology/Inflammation; Microbiology/Virology |
ZK 756326 是一种选择性的非肽 CCR8 趋化因子受体激动剂(IC50:1.8 μM,在人体内;2.6 μM,在小鼠体内)。对 CCR4/5 和 CXCR3/4 没有活性,比其他 26 种 GPCR 的选择性高 28 倍(对 α2A 和 5-HT 受体的选择性较低)。诱导趋化性并抑制 Env 介导的 (HIV) 细胞-细胞融合。 | |||
T16863 |
SCH 546738
|
Others | Others |
SCH 546738 is an effective and non-competitive CXCR3 antagonist. SCH 546738 bindings to the human CXCR3 receptor is determined (Ki: 0.4 nM) in multiple experiments. | |||
T12567 |
PS372424
|
Others | Others |
PS372424 is a specific agonist of human CXCR3, with anti-inflammatory activity. | |||
T70616 |
ACT-672125
|
||
ACT-672125 is a Potent CXCR3 Antagonist with Therapeutic Potential in Autoimmune Diseases. ACT-672125 showed good physicochemical properties and safety profile. In a proof-of-mechanism model of lung inflammation, ACT-672125 inhibited the recruitment of CXCR3 expressing T cells into the inflamed lung in a dose-dependent manner. | |||
T70411 |
PS372424 HCl
|
||
PS372424 is a specific agonist of human CXCR3. It has been shown to induce phosphorylation of ERK and block CXCL11 induced migration of CD45+ cells to air pouches generated on humanized mice. | |||
T24949 |
VUF10132
VUF-10132,VUF 10132 |
||
VUF10132 is a full inverse CXCR3 N3.35A agonist. | |||
T29147 |
VUF5834
VUF-5834,VUF 5834 |
||
VUF5834 is a full inverse agonist of CXCR3 N3.35A. | |||
T22477 |
(±)-AMG 487
|
Others | Others |
AMG 487 is an effective and selective antagonist of chemokine receptor 3. AMG 487 inhibited CXCR3-mediated cell migration induced by three CXCR3 chemokines, IP-10, ITAC and MIG (IC50: 8, 15 and 36 nM, respectively). | |||
T10297 | AMG 487 (S-enantiomer) | Others | Others |
AMG 487 S-enantiomer is the S enantiomer of AMG 487. AMG 487 is an CXCR3 antagonist. | |||
T63761 |
ACT-660602
|
||
ACT-660602 是口服具有活力的趋化因子受体 CXCR3 拮抗剂 (IC50: 204 nM)。ACT-660602 能够抑制 T 细胞迁移,并在体内急性肺损伤模型中显示出显著作用。ACT-660602 能够用于研究自身免疫性疾病。 | |||
T23656 |
VUF11211
VUF-11211,VUF 11211 |
||
VUF11211 is an effective antagonist of CXCR3 that acts by extending from the minor pocket into the major pocket of the transmembrane domains. | |||
T73148 |
ACT-777991
|
||
ACT-777991为一种选择性、口服生效的CXCR3拮抗剂,于动物模型中展现出微粒体及肝细胞稳定性,能抑制活化T细胞向CXCL11迁移。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3765 |
L-asarinin
細辛素,(-)-Episesamin |
Others | Others |
L-asarinin ((-)-Episesamin) 降低外周血 IL-12 浓度并抑制 CXCR3 和 TLR4 的表达,这意味着 Asarinin 可能在 TLR4 通路中发挥作用,并延长同种异体心脏的存活时间。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-01162 |
CXCR3 Protein, Human, Recombinant (GST & His)
IP-10 receptor,CXCR3,CXC-R3,GPR9,... |
Human | E. coli |
CXCR3 Protein, Human, Recombinant (GST & His) is expressed in E. coli. | |||
TMPH-02612 |
CXCR3 Protein, Mouse, Recombinant (His & KSI)
CXC-R3,CKR-L2,CXCR3,CD183 |
Mouse | E. coli |
Receptor for the C-X-C chemokine CXCL9, CXCL10 and CXCL11 and mediates the proliferation, survival and angiogenic activity of mesangial cells through a heterotrimeric G-protein signaling pathway. Probably promotes cell chemotaxis response. Binds to CCL21. | |||
TMPY-03274 |
CXCL11 Protein, Human, Recombinant
SCYB9B,I-TAC,chemokine (C-X-C motif) ligand 11,H174,SCYB11,I... |
Human | E. coli |
I-TAC, also known as CXCL11, is a small cytokine belonging to the CXC chemokine family. It is highly expressed in peripheral blood leukocytes, pancreas and liver, with moderate levels in thymus, spleen and lung and low expression levels were in small intestine, placenta and prostate. The I-TAC chemokine elicits its effects on its target cells by interacting with the cell surface chemokine receptor CXCR3, with a higher affinity than do the other ligands for this receptor, CXCL9 and CXCL10. I-TAC ... | |||
TMPJ-00008 |
CXCL10 Protein, Human, Recombinant (hFc & His)
INP10,10 kDa Interferon Gamma-Induced Protein,C-X-C Motif Ch... |
Human | HEK293 Cells |
Human C-X-C Motif Chemokine Ligand 10 (CXCL10) is a non-ELR chemokine secreted by various cell types, such as monocytes, endothelial cells and fibroblasts, in response to IFN-γ. CXCL10 functions via chemokine receptor CXCR3. CXCL10 has been attributed to several roles, such as chemoattraction for activated T-lymphocytes, inhibition of angiogenesis, and antitumor activity. | |||
TMPJ-00884 |
CXCL9 Protein, Mouse, Recombinant (His)
Protein m119,C-X-C motif chemokine 9,γ-interferon-induced mo... |
Mouse | HEK293 Cells |
Chemokine (C-X-C motif) ligand 9 (CXCL9, MIG), is a small cytokine belonging to the CXC chemokine family. CXCL9 functions as one of the three ligands of chemokine receptor CXCR3 which is a G protein-coupled receptor found predominantly on T cells. It together with CXCL10 and CXCL11, may activate CXCR3 by binding to it. CXCL9 serves as a cytokine that affects the growth, movement, or activation state of cells that participate in immune and inflammatory response. It has been observed that tumour e... | |||
TMPJ-01084 |
CXCL9 Protein, Human, Recombinant (His)
Monokine Induced by Interferon-γ,Gamma-Interferon-Induced Mo... |
Human | HEK293 Cells |
Chemokine (C-X-C Motif) Ligand 9 (CXCL9) belongs to the intercrine alpha (chemokine CXC) family. It is secreted by interferon stimulated monocytes, macrophages and endothelial cells, which elicits chemotactic functions by interacting with the chemokine receptor CXCR3. CXCL9 acts as a Th1 (type 1 helper T) cell chemoattractant and plays a role in the growth, activation and movement of cells associated with immune and inflammatory responses, and in tumour growth inhibition. It is closely related t... | |||
TMPJ-00012 |
CXCL4 Protein, Human, Recombinant (His)
SCYB4,PF4,Iroplact,Platelet Factor 4,PF-4,Oncostatin-A,CXCL4... |
Human | HEK293 Cells |
Human Chemokine (C-X-C motif) Ligand 4 (CXCL4) is expressed in megakaryocytes and stored in the alpha-granules of platelets. CXCL4 contains several heparin-binding sites at the C-terminal region and binds heparin with high affinity. The active CXCL4 protein is a tetramer. Human and mouse CXCL4 share 64% sequence identity. CXCL4 is chemotactic for neutrophils, fibroblasts and monocytes and plays a critical role in inflammation and wound repair. CXCL4 functions via a splice variant of the chemokin... |